Travere Therapeutics, Inc. (TVTX)
47.16
-1.14
(-2.36%)
USD |
NASDAQ |
Nov 20, 15:43
Travere Therapeutics 30-Day Average Daily Volume : 2.007M for Nov. 19, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| November 19, 2026 | 2.007M |
| November 18, 2026 | 2.002M |
| November 17, 2026 | 2.087M |
| November 16, 2026 | 2.144M |
| November 13, 2026 | 2.192M |
| November 12, 2026 | 2.226M |
| November 11, 2026 | 2.286M |
| November 10, 2026 | 2.312M |
| November 09, 2026 | 2.328M |
| November 06, 2026 | 2.300M |
| November 05, 2026 | 2.306M |
| November 04, 2026 | 2.292M |
| November 03, 2026 | 2.227M |
| November 02, 2026 | 2.028M |
| October 30, 2026 | 1.984M |
| October 29, 2026 | 2.020M |
| October 28, 2026 | 2.014M |
| October 27, 2026 | 2.036M |
| October 26, 2026 | 1.991M |
| October 23, 2026 | 1.910M |
| October 22, 2026 | 1.871M |
| October 21, 2026 | 1.864M |
| October 20, 2026 | 1.833M |
| October 19, 2026 | 1.810M |
| October 16, 2026 | 1.801M |
| Date | Value |
|---|---|
| October 15, 2026 | 1.777M |
| October 14, 2026 | 1.748M |
| October 13, 2026 | 1.715M |
| October 12, 2026 | 1.722M |
| October 09, 2026 | 1.702M |
| October 08, 2026 | 1.693M |
| October 07, 2026 | 1.679M |
| October 06, 2026 | 1.615M |
| October 05, 2026 | 1.546M |
| October 02, 2026 | 1.512M |
| October 01, 2026 | 1.490M |
| September 30, 2026 | 1.461M |
| September 29, 2026 | 1.438M |
| September 28, 2026 | 1.438M |
| September 25, 2026 | 1.437M |
| September 24, 2026 | 1.439M |
| September 23, 2026 | 1.415M |
| September 22, 2026 | 1.401M |
| September 21, 2026 | 1.356M |
| September 18, 2026 | 1.344M |
| September 17, 2026 | 1.365M |
| September 16, 2026 | 1.529M |
| September 15, 2026 | 1.537M |
| September 14, 2026 | 1.531M |
| September 11, 2026 | 1.557M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Vertex Pharmaceuticals, Inc. | 1.518M |
| TG Therapeutics, Inc. | 1.906M |
| Viridian Therapeutics, Inc. | 2.697M |
| Arrowhead Pharmaceuticals, Inc. | 2.135M |
| BioMarin Pharmaceutical, Inc. | 2.551M |